Song Xu-dong, Chen Cui-zhen, Dong Bing, Shi Yu-ying, Zhang Wei, Yan Liu-shui, Luo Guo-an
Department of Ophthalmology, Beijing Tongren Ophthalmic Center, The Capital Medical University, Beijing 100730, China.
Zhonghua Yan Ke Za Zhi. 2003 Oct;39(10):605-9.
To investigate the effects of various concentrations of taurine on streptozotocin (STZ)-induced diabetic cataracts in rats by biochemistry, radioimmunology and capillary zone electrophoresis (CZE).
One hundred Sprague-Dowley (SD) male rats, weight 180 approximately 200 g, were randomly divided into 5 groups: normal control, STZ plus saline, STZ plus 2% taurine, STZ plus 4% taurine and STZ plus 8% taurine groups. After being fasted for 12 hours, the rats of the STZ group (with or without taurine) were prepared by STZ intraperitoneal injection (55 mg/kg b.w.). Taurine-treated groups received 2%, 4% and 8% taurine injections once daily for 12 weeks (5 ml/kg b.w.). STZ group without taurine received a saline injection once daily for 12 weeks (5 ml/kg b.w.). During the experiment period, blood sugar was measured by ONE TOUCH II. At the end of experiment, several biochemical parameters were measured by Beckman CX-7, insulin was measured by (125)I-insulin radioimmunological detecting kit and the level of taurine in the aqueous humor and the lens was measured by Beckman 5500 capillary zone electrophoresis (CZE) model.
Three weeks after the administration of STZ, the lenses showed vesicle and light opacity in the STZ group. Taurine suppressed the occurrence of early stage cataract obviously. Four to 12 weeks after the administration of STZ, the lens opacity in the 4% and 8% taurine treatment groups was markedly delayed as compared with that of the STZ group. The level of blood glucose in the 4% and 8% taurine groups was decreased evidently compared to that of the STZ group on 4 days, 4 weeks, and 8 weeks (the 4% taurine group). No difference could be detected between the STZ group and taurine treatment groups in 12 weeks. In the 4% and 8% taurine groups, the level of triglycerides decreased markedly compared to that of the STZ group and was near that of the control group. There were no differences of other biochemical parameters among all groups. In the 8% taurine group, the level of taurine in the aqueous humor and lens was increased obviously compared to that of the STZ group (P = 0.036 or P = 0.000, respectively).
The intervening effect of taurine on STZ-induced diabetic cataract is dose-dependent. This effect is not only related to decreases in the levels of blood sugar and triglycerides, but is also related to an increase in the taurine level in the aqueous humor and lens of diabetic rats, which enables the lens to escape from oxidant injury.
通过生物化学、放射免疫学和毛细管区带电泳(CZE)研究不同浓度的牛磺酸对链脲佐菌素(STZ)诱导的大鼠糖尿病性白内障的影响。
100只体重约180至200g的Sprague-Dawley(SD)雄性大鼠随机分为5组:正常对照组、STZ加生理盐水组、STZ加2%牛磺酸组、STZ加4%牛磺酸组和STZ加8%牛磺酸组。禁食12小时后,STZ组(含或不含牛磺酸)大鼠通过腹腔注射STZ(55mg/kg体重)制备糖尿病模型。牛磺酸处理组每天注射2%、4%和8%牛磺酸,共12周(5ml/kg体重)。未加牛磺酸的STZ组每天注射生理盐水,共12周(5ml/kg体重)。实验期间,用ONE TOUCH II血糖仪测量血糖。实验结束时,用Beckman CX-7测定多项生化参数,用(125)I-胰岛素放射免疫检测试剂盒测定胰岛素,用Beckman 5500毛细管区带电泳(CZE)模型测定房水和晶状体中牛磺酸的水平。
STZ给药3周后,STZ组晶状体出现水泡和轻度混浊。牛磺酸明显抑制早期白内障的发生。STZ给药4至12周后,4%和8%牛磺酸处理组的晶状体混浊明显比STZ组延迟。4%和8%牛磺酸组在第4天、4周和8周(4%牛磺酸组)时血糖水平明显低于STZ组。12周时,STZ组与牛磺酸处理组之间未检测到差异。在4%和8%牛磺酸组中,甘油三酯水平明显低于STZ组,接近对照组水平。所有组间其他生化参数无差异。8%牛磺酸组房水和晶状体中牛磺酸水平明显高于STZ组(分别为P = 0.036或P = 0.000)。
牛磺酸对STZ诱导的糖尿病性白内障的干预作用呈剂量依赖性。这种作用不仅与血糖和甘油三酯水平降低有关,还与糖尿病大鼠房水和晶状体中牛磺酸水平升高有关,从而使晶状体免受氧化损伤。